Corona Remedies Ltd. - Research Center

---

Results

• Annual

Statement

More

Mar ' 25	Mar ' 24	Mar ' 23	Mar ' 22	Mar ' 21

Sales

1,196.42

1,014.47

884.05

617.33

576.16

Operating profit

239.98

154.74

127.98

17.82

105.39

Interest

10.60

14.44

4.27

4.73

2.01

Gross profit

235.31

146.76

130.76

19.69

108.32

EPS (Rs)

24.37

14.80

13.85

-0.08

150.71

Other income

5.94

6.46

7.05

6.60

4.94

Stock adjustment

-23.74

-0.78

-14.51

-40.57

-2.72

Raw material

102.29

102.73

99.09

73.07

52.45

Power and fuel

-

-

-

-

-

Employee expenses

346.14

295.37

254.77

226.65

176.36

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

531.76

462.42

416.71

340.36

244.68

Provisions made

-

-

-

-

-

Depreciation

37.16

28.28

20.10

20.48

15.89

Taxation

49.10

27.98

25.96

-0.39

22.49

Net profit / loss

149.05

90.50

84.70

-0.40

69.95

Extra ordinary item

-

-

-

-

-

Prior year adjustments

-

-

-

-

-

Equity capital

61.16

61.16

61.16

51.05

4.64

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

20.06

15.25

14.48

2.89

18.29

GPM (%)

19.57

14.37

14.67

3.16

18.64

NPM (%)

12.40

8.86

9.51

-0.06

12.04